Management of hereditary angioedema
Intended for healthcare professionals
Art & Science Previous     Next

Management of hereditary angioedema

John Dempster Senior clinical nurse specialist, The Royal London Hospital, London

Hereditary angioedema is characterised by unpredictable, painful and potentially life-threatening oedema. Recently, some C1 inhibitors have been approved for self-administration and/or routine prevention, enabling patients to be proactive in managing their disease and reducing the burden of illness. This article discusses the effect of these advances from a specialist nurse’s perspective.

Nursing Standard. 27, 37, 35-40. doi: 10.7748/ns2013.


Peer review

This article has been subject to double blind peer review

Conflict of interest

The author has performed consultancy work for CSL Behring, Shire and ViroPharma. Medical writing assistance was provided by Shilpa Aggarwal, ApotheCom ScopeMedical, funded by ViroPharma Ltd.

Accepted: 14 January 2013

Want to read more?

Already subscribed? Log in


Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now